--- title: "Aker BioMarine Registers Share Capital Increase from Employee Share Program" type: "News" locale: "en" url: "https://longbridge.com/en/news/278917834.md" description: "Aker BioMarine Registers Share Capital Increase from Employee Share Program" datetime: "2026-03-12T16:34:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278917834.md) - [en](https://longbridge.com/en/news/278917834.md) - [zh-HK](https://longbridge.com/zh-HK/news/278917834.md) --- # Aker BioMarine Registers Share Capital Increase from Employee Share Program Aker BioMarine Registers Share Capital Increase from Employee Share Program ### Related Stocks - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [AKBA.US](https://longbridge.com/en/quote/AKBA.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [BMRN.US](https://longbridge.com/en/quote/BMRN.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [AKRO.US](https://longbridge.com/en/quote/AKRO.US.md) ## Related News & Research - [BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency | BMRN Stock News](https://longbridge.com/en/news/286776398.md) - [BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia | BMRN Stock News](https://longbridge.com/en/news/287114244.md) - [BioMarin's drug shows significant growth gains in children in late-stage trial](https://longbridge.com/en/news/287121584.md) - [BioMarin drug acquired in buyout misses goal in rare disease study](https://longbridge.com/en/news/287075291.md) - [Capricor publishes investor presentation on deramiocel Duchenne muscular dystrophy program](https://longbridge.com/en/news/287222906.md)